FDA Approves Japanese Lower-Body Exoskeleton

Cyberdyne’s Hybrid Assistive Limb is a robotic device that helps people with lower limb disabilities walk on their own.

Cyberdyne's HAL / Image: Cyberdyne
Cyberdyne's HAL / Image: Cyberdyne

A recent article from IEEE Spectrum reported on the FDA’s approval of a medical device that increases the mobility of people with lower limb disabilities. The robotic device, known as HAL (Hybrid Assistive Limb), is a lower-body exoskeleton that is strapped to the user’s legs and increases their strength by a factor of up to ten. HAL’s sensors detect bioelectric signals from the brain that instruct it to power up and assist in moving.

The FDA approved a specific version of Cyberdyne’s robot called HAL for Medical Use, which will be sold in the United States via licensed medical facilities. It has been available in Japan for several years; a video of HAL in use can be seen here.

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026